Prevalence of aspirin resistance by thromboelastography plus platelet mapping in children with CHD: a single-centre experience.
Adolescent
Adult
Aspirin
/ pharmacology
Cardiac Surgical Procedures
/ adverse effects
Child
Child, Preschool
Drug Resistance
Female
Heart Defects, Congenital
/ surgery
Humans
Infant
Logistic Models
Male
Platelet Aggregation
/ drug effects
Platelet Aggregation Inhibitors
/ pharmacology
Postoperative Complications
/ prevention & control
Prevalence
Retrospective Studies
Thrombelastography
Thromboembolism
/ prevention & control
Young Adult
Aspirin resistance
CHD
general cardiology
platelet mapping
thromboelastography
Journal
Cardiology in the young
ISSN: 1467-1107
Titre abrégé: Cardiol Young
Pays: England
ID NLM: 9200019
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
7
12
2018
medline:
30
4
2019
entrez:
4
12
2018
Statut:
ppublish
Résumé
RationaleAspirin resistance has been reported in up to 80% of children with cardiovascular defects undergoing surgery. Because of a patient who had embolic stroke while on therapeutic aspirin dose but in whom aspirin resistance was present on his thromboelastography platelet mapping, we chose to obtain thromboelastography platelet mapping on cardiac patients on aspirin to assess their risk. OBJECTIVES: This study evaluates aspirin resistance noted in these patients and their characteristics.Methods and resultsThis is a retrospective study of 25 patients taking aspirin for a month at therapeutic dose. In total, 11 female patients were enrolled. Ages in all subjects were 5 months to 27 years. A total of 19 patients had a Fontan surgery. Three had a cavopulomanary anastomosis, one had a hybrid procedure, and two had coronary anomalies. Compliance was assessed at the time of the clinic visit. Aspirin resistance was defined as platelet inhibition below 50%. Variables evaluated were level of platelet inhibition, age, body mass index, and gender.
Identifiants
pubmed: 30501653
pii: S1047951118000021
doi: 10.1017/S1047951118000021
doi:
Substances chimiques
Platelet Aggregation Inhibitors
0
Aspirin
R16CO5Y76E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM